Cardiovascular Prophylaxis and Aspirin " Allergy"

Immunology and Allergy Clinics of North America

Volumn 33, Issue 2, 2013, Pages 263-274

  Woessner, Katharine M ^a   Simon, Ronald A ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

Acetylsalicylic acid; Aspirin exacerbated respiratory disease; Coronary artery disease; Cyclooxygenase; Nonsteroidal anti inflammatory drug

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLOPIDOGREL; CORTICOSTEROID; LONG ACTING DRUG; MONTELUKAST; NONSTEROID ANTIINFLAMMATORY AGENT;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASPIRIN EXACERBATED RESPIRATORY DISEASE; CAPILLARY RESISTANCE; CARDIOVASCULAR DISEASE; CHEMOPROPHYLAXIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DESENSITIZATION; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SAFETY; GASTRITIS; HUMAN; LACRIMATION; LOW DRUG DOSE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PREVALENCE; PRIORITY JOURNAL; PROVOCATION TEST; PRURITUS; REVIEW; RHINORRHEA; SIDE EFFECT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS; URTICARIA;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CARDIOVASCULAR DISEASES; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; HUMANS; PREMEDICATION;

EID: 84877016602     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2012.11.004     Document Type: Review

References (34)

1. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324:71-86. Antithrombotic Trialists Collaboration.
2. Ryan T.J., Antman E.M., Brooks N.H., et al. 1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999, 100:1016-1030.
3. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation 2000, 102:1193-1209.
4. Sabatine M.S., Cannon C.P., Gibson C.M., et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005, 352:1179-1189.
5. Yusuf S., Zhao F., Mehta S.R., et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001, 345:494-502.
6. Mehta S.R., Yusuf S., Peters R.J., et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001, 358:527-533.
7. Steinhubl S.R., Berger P.B., Mann J.T., et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002, 288:2411-2420.
8. Smith S.C., Feldman T.E., Hirshfeld J.W., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006, 113:e166-e286.
9. Gaspoz J.M., Coxson P.G., Goldman P.A., et al. Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med 2002, 346:1800-1806.
10. Settipane R.A., Constantine H.P., Settipane G.A. Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review. Allergy 1980, 35:149-154.
11. Gomes E., Cardoso M.F., Praca F., et al. Self-reported drug allergy in a general adult Portuguese population. Clin Exp Allergy 2004, 34:1597-1601.
12. Kowalski M.L., Makowska J.S., Blanca M., et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)-classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*. Allergy 2011, 66:818-829.
13. Hedman J., Kaprio J., Poussa T., et al. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999, 28:717-722.
14. Jenkins C., Costello J., Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004, 328:434.
15. Moore-Robinson M., Warin R.P. Effect of salicylates in urticaria. Br Med J 1967, 4:262-264.
16. Solensky R. Drug allergy: desensitization and treatment of reactions to antibiotics and aspirin. Allergens and allergen immunotherapy 2004, 585-606. Marcel Dekker, New York. P. Lockey (Ed.).
17. Szczeklik A., Nizankowska-Mogilnicka E., Sanak M. Hypersensitivity to aspirin and non-steroidal anti-inflammatory drugs. Middleton's allergy: principles and practice 2008, 1227-1239. Mosby, Philadelphia. N.F. Adkinson, B.S. Bochner, W.W. Busse (Eds.).
18. Grattan C.E. Aspirin sensitivity and urticaria. Clin Exp Dermatol 2003, 28:123-127.
19. Mathison D.A., Lumry W.R., Stevenson D.D. Aspirin in chronic urticaria and/or angioedema: studies of sensitivity and desensitization. J Allergy Clin Immunol 1982, 69:135.
20. Doeglas H.M. Reactions to aspirin and food additives in patients with chronic urticaria, including the physical urticarias. Br J Dermatol 1975, 93:135-144.
21. Kemp S.F., Lockey R.F., Wolf B.L., et al. Anaphylaxis. A review of 266 cases. Arch Intern Med 1995, 155:1749-1754.
22. Phills J.A., Perelmutter L. IgE mediated and non-IgE mediated allergic-type reactions to aspirin. Acta Allergol 1974, 29:474-490.
23. Blanca M., Perez E., Garcia J.J., et al. Angioedema and IgE antibodies to aspirin: a case report. Ann Allergy 1989, 62:295-298.
24. De Luca G., Verdoia M., Binda G., et al. Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience. Int J Cardiol 2012, [Epub ahead of print].
25. McMullan K.L., Wedner H.J. Safety of aspirin desensitization in patients with reported aspirin allergy and cardiovascular disease. Clin Cardiol 2012, [Epub ahead of print].
26. Fajt M.L., Petrov A.A. Outpatient aspirin desensitization for patients with aspirin hypersensitivity and cardiac disease. Crit Pathw Cardiol 2011, 10:17-21.
27. Wong J.T., Nagy C.S., Krinzman S.J., et al. Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema. J Allergy Clin Immunol 2000, 105:997-1001.
28. Rossini R., Angiolillo D.J., Musumeci G., et al. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation. Am J Cardiol 2008, 101:786-789.
29. Dalmau G., Gaig P., Gazquez V., et al. Rapid desensitization to acetylsalicylic acid in acute coronary syndrome patients with NSAID intolerance. Rev Esp Cardiol 2009, 62:224-225.
30. Silberman S., Neukirch-Stoop C., Steg P.G. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting. Am J Cardiol 2005, 95:509-510.
31. Ortega-Loayza A.G., Raza S., Minisi A.J., et al. Aspirin desensitization/challenge in 3 patients with unstable angina. Am J Med Sci 2010, 340:418-420.
32. Mehta S.R., Tanguay J.F., Eikelboom J.W., et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet 2010, 376:1233-1243.
33. Stevenson D.D., Simon R.A. Selection of patients for aspirin desensitization treatment. J Allergy Clin Immunol 2006, 118:801-804.
34. Slowik S.M., Slavin R.G. Aspirin desensitization in a patient with aspirin sensitivity and chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2009, 102:171-172.